These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17595792)

  • 1. Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer.
    Yoshimatsu K; Yokomizo H; Fujimoto T; Umehara A; Otani T; Matsumoto A; Osawa G; Ogawa K
    Anticancer Res; 2007; 27(3B):1657-61. PubMed ID: 17595792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with S-1 plus CPT-11 for lymph node metastasis from colon cancer: report of a case.
    Yoshimatsu K; Yokomizo H; Fujimoto T; Otani T; Matsumoto A; Osawa G; Itagaki H; Umehara A; Shiozawa S; Katsube T; Naritaka Y; Ogawa K
    Anticancer Res; 2008; 28(1B):559-62. PubMed ID: 18383902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304.
    Ishida H; Miyake Y; Fukunaga M; Watanabe Y; Kato T; Takemoto H; Furukawa H
    Jpn J Clin Oncol; 2009 Sep; 39(9):601-5. PubMed ID: 19535386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer.
    Oh SY; Ju YT; Choi SK; Ha CY; Lee WS; Kim HG; Lee GW; Kwon HC; Kang JH
    Invest New Drugs; 2011 Oct; 29(5):1050-6. PubMed ID: 20238142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer.
    Yamaguchi Y; Minami K; Kawabuchi Y; Ohshita A; Hironaka K
    Hepatogastroenterology; 2008; 55(82-83):407-11. PubMed ID: 18613376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer.
    Yamada Y; Yamaguchi T; Matsumoto H; Ichikawa Y; Goto A; Kato K; Hamaguchi T; Shimada Y
    Invest New Drugs; 2012 Aug; 30(4):1690-6. PubMed ID: 21894500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of quality of life by questionnaires between S-1/CPT-11 and mFOLFOX6 in patients with advanced colorectal cancer].
    Tokunaga Y; Sasaki H; Matsueda S
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1127-31. PubMed ID: 21772096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.
    Goto A; Yamada Y; Yasui H; Kato K; Hamaguchi T; Muro K; Shimada Y; Shirao K
    Ann Oncol; 2006 Jun; 17(6):968-73. PubMed ID: 16603600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.
    Tsunoda A; Yasuda N; Nakao K; Narita K; Watanabe M; Matsui N; Kusano M
    Oncology; 2009; 77(3-4):192-6. PubMed ID: 19729976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer.
    Shiozawa M; Akaike M; Sugano N; Tsuchida K; Yamamoto N; Morinaga S
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):987-92. PubMed ID: 20623226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line combination chemotherapy of oral S-1 with cisplatin and irinotecan for colorectal cancer resistant to 5-FU.
    Tsutsumi S; Yamaguchi S; Ide M; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
    Hepatogastroenterology; 2006; 53(68):196-200. PubMed ID: 16608023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin.
    Yasui H; Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamazaki K; Taku K; Kojima T; Machida N
    Jpn J Clin Oncol; 2009 May; 39(5):315-20. PubMed ID: 19403734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.
    Tsunoda A; Yasuda N; Nakao K; Narita K; Yamazaki K; Watanabe M; Suzuki N; Kusano M
    Oncology; 2007; 72(1-2):58-63. PubMed ID: 17998791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose chemotherapy with leucovorin plus 5-fluorouracil for colorectal cancer can maintain host immunity.
    Kobayashi R; Yoshimatsu K; Yokomizo H; Katsube T; Ogawa K
    Anticancer Res; 2007; 27(1B):675-9. PubMed ID: 17348459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
    Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
    Dig Dis; 2007; 25(1):100-5. PubMed ID: 17384515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
    Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.
    Choi YH; Kim TW; Lee SS; Hong YS; Ryu MH; Lee JL; Chang HM; Kang YK
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):905-12. PubMed ID: 21290246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
    Tsavaris N; Ziras N; Kosmas C; Giannakakis T; Gouveris P; Vadiaka M; Dimitrakopoulos A; Karadima D; Rokana S; Papalambros E; Papastratis G; Margaris H; Tsipras H; Polyzos A
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):514-9. PubMed ID: 14504920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer].
    Goto A
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
    Souglakos J; Pallis A; Kakolyris S; Mavroudis D; Androulakis N; Kouroussis C; Agelaki S; Xenidis N; Milaki G; Georgoulias V
    Oncology; 2005; 69(5):384-90. PubMed ID: 16319509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.